Abstract

In addition to sensory disturbances, neuropathic pain is associated with an ongoing and persistent negative affective state. This condition may be reflected as altered sensitivity to rewarding stimuli. We examined this hypothesis by testing whether the rewarding properties of morphine are altered in a rat model of neuropathic pain. Neuropathic pain was induced by chronic constriction of the common sciatic nerve. Drug reward was assessed using an unbiased, three-compartment conditioned place preference (CPP) paradigm. The rats underwent two habituation sessions beginning 6 days after surgery. Over the next 8 days, they were injected with drug or vehicle and were confined to one CPP compartment for 30 min. On the following test day, the rats had access to all three compartments for 30 min. Consistent with the literature, systemic administration of morphine dose-dependently increased the CPP in pain-naive animals. In rats with neuropathic pain, however, the dose-dependent effects of morphine were in a bell-shaped curve, with a low dose of morphine (2 mg/kg) producing a greater CPP than a higher dose of morphine (8 mg/kg). In a separate group of animals, acute administration of morphine reversed mechanical allodynia in animals with neuropathic pain at the same doses that produced a CPP. The increased potency of systemic morphine to produce a CPP in animals with neuropathic pain suggests that the motivation for opioid-induced reward is different in the two states.

Highlights

  • Neuropathic pain, caused by various central and peripheral nerve disorders, results in chronic and intractable pain

  • In addition to sensory disturbances, neuropathic pain is associated with an ongoing and persistent negative affective state. This condition may be reflected as altered sensitivity to rewarding stimuli. We examined this hypothesis by testing whether the rewarding properties of morphine are altered in a rat model of neuropathic pain

  • Treatment of this condition is challenging as it is typically refractory to both conventional and nonconventional analgesics; the use of these medications is limited, further, by intolerable side-effects (Gilron et al, 2006; Dworkin et al, 2010)

Read more

Summary

Introduction

Neuropathic pain, caused by various central and peripheral nerve disorders, results in chronic and intractable pain. Treatment of this condition is challenging as it is typically refractory to both conventional (opioids) and nonconventional (antidepressants and antiepileptics) analgesics; the use of these medications is limited, further, by intolerable side-effects (Gilron et al, 2006; Dworkin et al, 2010). The negative affect, or how much the pain is ‘bothersome’, significantly impacts the quality of life of the sufferer and leads to the common comorbidities of psychiatric disorders such as depression. Chronic pain is second only to bipolar disease as the major cause of suicide among all medical illnesses, further highlighting the importance of negative affect in this condition (Juurlink et al, 2004)

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call